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EDITORIAL
In honour of Professor Leaf Huang, recipient of the Journal of Drug Targeting’s
life-time achievement award for 2018
A photograph of Professor Leaf Huang, recipient of the Journal of
Drug Targeting’s Lifetime Achievement Award for 2018.
It is time for this Journal to honour the recipient of this year’s Life-
time Achievement Award. The Journal of Drug Targeting’s Life-time
Achievement Award is an un-solicited award given annually to
honour the sustained outstanding scientific achievements of a
researcher working in the broad fields of drug delivery and target-
ing. This year’s winner, as in previous years, was selected by a
scientific panel comprising members of the Editorial board and
representatives from Taylor and Francis (part of Informa
Healthcare UK), the publishers of Journal of Drug Targeting.
It gives me great pleasure to announce that Professor Leaf
Huang, of the University of North Carolina at Chapel Hill (UNC-CH),
North Carolina, USA, is the recipient of this year’s Journal of Drug
Targeting’s Lifetime Achievement Award for his life-long research
into drug delivery and targeting systems, especially for gene- and
nucleic acid-based therapies. Professor Huang is currently the Fred
Eshelman Distinguished Professor at the Eshelman School of
Pharmacy at UNC-CH and was previously a faculty member at the
University of Tennessee, Knoxville (1976–1991) and at the
University of Pittsburgh (1991–2005). It was in July 2005 that he
moved to his present affiliation at the UNC Eshelman School of
Pharmacy to become chair of the Division of Molecular
Pharmaceutics, a position he had held until 2012. However, Leaf
began his academic life by graduating in 1968 with a physics
major (even though he preferred biology!) from the National
Taiwan University, Taipei. He then obtained a PhD degree in bio-
physics from the Michigan State University in 1974 before first
learning about liposomes as a post-doctoral fellow in Richard
Pagano’s research group at Carnegie Institute of Washington, USA.
How important that first encounter with liposomes must
have been as Professor Huang then went onto become an
important pioneer of liposomal delivery of genes and other
nucleic acid-based therapies including antisense, siRNA and
immune-stimulatory oligonucleotides as well as other small
molecular weight drugs. He has published well over 500 research
articles and patents with a h-index of 115 (as per his google
scholar profile). He has published in many of the top scientific
journals including Nature, Nature Medicine, Nature Communications
and Proceedings of the National Academy of Sciences. The high
quality of his research is further attested to by his papers receiving
well over 52,000 citations to date. His work is clearly translational
and clinically relevant and as such, he has been involved in setting
up several business enterprises including Lipogen, Rx
Therapeutics, Lipella and PDS Biotechnology. In his long and illus-
trious career, Prof Huang has also mentored well over 100 gradu-
ate students and post-doctoral fellows, many of whom have gone
on to have successful academic careers of their own.
Indeed, I am extremely grateful to one of Leaf’s former gradu-
ate students, Professor Shyh-Dar Li, of the Faculty of
Pharmaceutical Sciences, University of British Columbia, Vancouver
BC, Canada, for agreeing to be the Guest Editor and for compiling
this special issue in honour of the awardee. The print copy of this
special issue, along with a commemorative plaque will be awarded
to Professor Huang as part of the award.
Professor Shyh-Dar Li has assembled an excellent combination
of reviews and original articles that give a flavour of the type of
research Professor Leaf Huang and his group has been conducting
over the many years of his service in academia. In this special
issue, Shyh-Dar Li’s own Guest Editorial highlights the research
achievements of Leaf Huang that have led up to this prestigious
award from the Journal of Drug Targeting and I refer readers to his
excellent editorial for further details.
As you will see from Shyh-Dar Li’s Guest Editorial and my own
brief comments above, that, without a shadow of doubt, Prof Leaf
Huang is an extremely well deserving recipient of this award. The
Journal of Drug Targeting is therefore very delighted to award its
Life-time Achievement Award for 2018 to Professor Leaf Huang for
his many outstanding contributions to drug delivery and targeting.
Our congratulations to you, Leaf and as our best wishes to you
and your family for the future!
Saghir Akhtar
Editor-in-Chief, Journal of Drug Targeting
College of Medicine, Qatar University, Doha, Qatar
journaldrugtargeting@googlemail.com, s.akhtar@qu.edu.qa
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